Publications by authors named "I Catalaa"

Claim this Profile
R
Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial).
Anne Laprie, Georges Noel, Leonor Chaltiel, Gilles Truc, Marie-Pierre Sunyach, Isabelle Catalaa

Neuro Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the hypervascularized fraction of glioblastomas using a volume analysis of dynamic susceptibility contrast-enhanced MRI may help to identify pseudoprogression.
Margaux Roques, Isabelle Catalaa, Magali Raveneau, Justine Attal, Aurore Siegfried

PLoS One· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducibility of volume analysis of dynamic susceptibility contrast perfusion-weighted imaging in untreated glioblastomas.
Margaux Roques, Magali Raveneau, Gilles Adam, Amaury De Barros, Isabelle Catalaa

Neuroradiology· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Surgery on the Survival of Patients with Recurrent Glioblastoma.
Oumar Sacko, Alexandra Benouaich-Amiel, Pierre Brandicourt, Mahamadou Niaré, Saloua Charni, Isabelle Catalaa

Asian J Neurosurg· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of "CNS tumors with BCOR internal tandem duplication".
Arnault Tauziède-Espariat, Gaëlle Pierron, Aurore Siegfried, Delphine Guillemot, Emmanuelle Uro-Coste, Isabelle Catalaa

Acta Neuropathol Commun· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis